In a landmark agreement, Purdue Pharma, the manufacturer of OxyContin, and the Sackler family, its owners, have agreed to a $7.4 billion settlement to address the devastating impact of their painkiller on communities across the United States. The settlement, reached after years of litigation, is a significant step towards holding the company accountable for its role in fueling the opioid epidemic.
Purdue Pharma , the maker of the painkiller OxyContin, and its owners, the Sackler family, have agreed to a historic $7.4 billion settlement in a lawsuit stemming from the deadly toll of their drug. The opioid epidemic continues to devastate communities across the U.S., and on Thursday, a major step was taken toward addressing the fallout from this public health crisis. Teri Kroll, a mother from Lindenhurst, knows this pain all too well.
Her son, Timothy, struggled with addiction after being prescribed painkillers, including OxyContin. Tragically, Timothy died from an overdose in 2009, and Kroll has never stopped fighting for accountability. 'The Sacklers and their actions killed my son,' Kroll said, expressing her deep grief over the loss of her child. Her case is not unique. Many others who have lost loved ones to the opioid epidemic feel the same way – the lives lost are immeasurable, and no amount of money can bring them back. The $7.4 billion settlement reached Thursday is the result of years of litigation and will directly address the harm caused by OxyContin. Under the terms of the agreement, $6.5 billion will be paid by the Sackler family. Purdue Pharma will also give up ownership of the company, which has been at the center of the opioid crisis. In a statement, Purdue Pharma expressed its hope that the agreement would help compensate victims, reduce the opioid crisis, and fund programs that save lives. 'We are extremely pleased that a new agreement has been reached that will deliver billions of dollars to compensate victims, abate the opioid crisis, and deliver treatment and overdose rescue medicines that will save lives,' the company said. While the settlement is a significant step forward, experts are clear that the funds must be used effectively to help those still struggling with addiction. Steve Chassman, a drug treatment expert with the Long Island Council on Alcoholism and Drug Dependence, emphasized that the money must go directly to help those struggling with addiction. 'This is a monetary relief that hopefully will go to education, prevention, and will go to grief and loss counseling for families who are forever changed,' Chassman said. For him and others in the field, the hope is that these funds will help prevent further deaths and provide essential resources for people in recovery. While the settlement is a significant milestone, it still needs approval from the courts before it can take effect. The Attorney General for New York State expects the finalization to occur by the end of this year, with payments to be made over a period of 15 years
OPIOID EPIDEMIC PURDUE PHARMA SACKLER FAMILY OXYCONTIN LAWSUIT SETTLEMENT DRUG CRISIS ADDICTION
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Sackler Family and Purdue Pharma Agree to $7.4 Billion Settlement for Role in Opioid CrisisThe Sackler family and Purdue Pharma, the maker of OxyContin, have reached a $7.4 billion settlement with a coalition of 15 states over their role in fueling the opioid crisis. The deal bars the Sacklers from selling opioids in the U.S. and ends their control of Purdue.
Read more »
Purdue Pharma and Sackler Family Agree to $7.4 Billion Settlement in Opioid Crisis LawsuitsPurdue Pharma, the maker of OxyContin, and the Sackler family, which owns the company, have agreed to a $7.4 billion settlement to resolve thousands of lawsuits alleging their role in the opioid crisis. The deal is among the largest settlements ever reached in cases related to the epidemic.
Read more »
Purdue Pharma, Sackler Family Agree to $7.4 Billion Opioid SettlementPurdue Pharma, the maker of OxyContin, and the Sackler family agreed to a $7.4 billion settlement to resolve lawsuits over the company's role in the opioid crisis. The deal, which requires court approval, would see the Sacklers contribute up to $6.5 billion and relinquish ownership of Purdue. The settlement aims to compensate victims, abate the opioid epidemic, and fund treatment and overdose rescue medications.
Read more »
Sackler Family, Purdue Pharma Agree to $7.4 Billion Opioid SettlementThe Sackler family and Purdue Pharma, facing mass opioid litigation, have agreed to a $7.4 billion settlement. This marks the end of the costliest corporate bankruptcy stemming from the U.S. opioid crisis.
Read more »
Purdue Pharma and Sackler Family Agree to $7.4 Billion Settlement in Opioid Crisis LawsuitsA new settlement agreement has been reached between Purdue Pharma, the makers of OxyContin, and the Sackler family, who own the company. This deal, worth up to $7.4 billion, aims to address the devastating impact of the opioid crisis. The agreement replaces a previous deal that was blocked by a federal judge. This new settlement requires the Sackler family to give up ownership of Purdue Pharma and allocate substantial funds towards compensating victims and combating the opioid epidemic.
Read more »
Purdue Pharma, Sackler family owners agree to landmark $7.4B opioid settlementThe latest settlement is meant to address a drug addiction crisis that has led to over 700,000 opioid overdose deaths in the US over the past two decades.
Read more »